Devos, Johannes http://orcid.org/0000-0002-6623-3769
Devriendt, Koenraad http://orcid.org/0000-0002-3651-2548
Richter, Jute http://orcid.org/0000-0001-8415-6747
Jansen, Katrien http://orcid.org/0000-0002-5503-529X
Baldewijns, Marcella http://orcid.org/0000-0002-0882-2944
Thal, Dietmar R. http://orcid.org/0000-0002-1036-1075
Aertsen, Michael http://orcid.org/0000-0003-1994-5365
Article History
Received: 27 April 2023
Revised: 16 June 2023
Accepted: 20 June 2023
First Online: 17 July 2023
Declarations
:
: D.R.T. received speaker honorary from Novartis Pharma AG (Switzerland) and Biogen (USA) and travel reimbursement from GE-Healthcare (UK) and UCB (Belgium) and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK) and Janssen Pharmaceutical Companies (Belgium). D.R.T. receives grants from Fonds Wetenschappelijk Onderzoek (FWO (Vlaanderen): G0F8516N, G065721N), Stichting Alzheimer Onderzoek (SAO-FRA (Belgium): 2020/017) and KU-Leuven Internal Funding (C14/22/132; C3/20/057).